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Abstract
Methods. The cutaneous capillary lymphatic system in patients with systemic sclerosis was
investigated using fluorescence microlymphography. The distal upper limbs of 16 healthy
controls (mean age 62.3± 13.1 yr) and 16 patients with systemic sclerosis (mean age
58.9± 13.6 yr) were examined and the following parameters were evaluated: (a) single
lymphatic capillaries; (b) lymphatic capillary network and cutaneous backflow; (c) extension
of the stained lymphatics; (d) diameter of single lymphatic capillaries.
Results. At the finger level, lymphatic capillaries were lacking in five patients, while they
were present in all controls (P< 0.05). Extension of the stained lymphatics was increased in
11 patients (8.1± 6.0 mm) compared to the 16 healthy controls (2.0± 1.2 mm) (P< 0.0001).
Cutaneous backflow was observed in three patients (P< 0.05). At the hand level, lymphatic
network extension was significantly diVerent between patients (3.8± 2.4 mm) and controls
(1.2± 0.8 mm) (P< 0.01); however, no significant diVerences were found at the forearm level.
Conclusion. Lesional skin in patients with systemic sclerosis exhibits evidence of lymphatic
microangiopathy.
Key words: Systemic sclerosis, Lymphatics, Skin, Microangiopathy, Fluorescence micro-
lymphography.
Patients with systemic sclerosis show cutaneous blood The skin involvement of systemic sclerosis begins on
capillary microangiopathy characterized by dilated the fingers and hands in most cases, and the changes
capillaries, avascular fields and increased capillary usually proceed through three phases: early, classical
permeability [1, 2]. and late. The oedematous early phase often begins with
There are neither histological nor in vivo investigations painless swelling of the fingers and dorsum of the hand.
dealing with the microlymphatic system of the skin The subsequent classical indurative phase is character-
in this disease. This is surprising because lymphatic ized by firm, taut, hidebound skin. In the late atrophic
microangiopathy plays an important role in other dis- phase, the skin of the hands shows the ravages of the
eases with oedema, such as lymphoedema or chronic early active fibrotic period. Other skin manifestations
venous insuYciency [3–5], and oedema is an important include digital pitting scars, loss of finger-pad tissue,
part of the skin involvement in systemic sclerosis. To ulcers, telangiectasia and calcinosis [8–11]. The clinical
our knowledge, there are only two publications dealing impression that the oedema of the early phase regresses
with conventional lymphography in patients with sys- in the later course of the disease is discussed controver-
temic sclerosis [6, 7]. In a case report, rarefication of sially [11]. In fact, some data suggest that it does not.
the peripheral lymphatic channels was described [6 ]. In one study, uniform and trimmed punch biopsy speci-
Rauste [7] published a series of 349 lymphographies in mens from the forearm of patients with systemic sclerosis
granulomatous inflammations and connective tissue dis- were weighed before and after desiccation. The percent-
eases. He had incorporated two patients with sclero- age of tissue water weight was remarkably consistent in
derma, of whom one had pathological lymphographic all patients (around 70%), irrespective of their clinical
findings. classification, duration of disease, or degree of clinical
skin thickness and oedema at the site of biopsy [12].
Similar observations were noted in studies of skin core
Submitted 10 August 1998; revised version accepted 14 October
biopsy weights [13]. It is possible that the oedema does1998.
not resolve, but that the clinical ability to detect suchCorrespondence to: A. J. Leu, Department of Internal Medicine,
changes becomes more limited as the dermis becomesAngiology Division, University Hospital, Ra¨mistraße 100, CH-8091
Zurich, Switzerland. more fibrosed [11].
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In the literature, there are several hypotheses for the detail previously [15, 16 ]. Large molecules are exclus-
ively drained by the lymphatic system. Therefore, micro-origin of the oedema in systemic sclerosis. It may be
due to deposition of hydrophilic glycosaminoglycan in lymphatics may be visualized by macromolecular,
fluorescent materials injected into the subepidermal layerthe dermis, local inflammation, hydrostatic eVects or
enhanced microvascular permeability [11]. These factors of the skin. From the original interstitial deposit, the
dye moves into the superficial network of lymphaticmay in part account for the oedema. As an additional
explanation, involvement of the cutaneous lymphatic microvessels and renders them visible. The anatomy of
this system is well known from anatomical studiessystem in the oedema development may be postulated.
The purpose of this study was, therefore, to investigate [17, 18].
Using a steel microcannula with a tip diameter ofthe microlymphatic system of the skin at the distal upper
extremity in patients with systemic sclerosis. 0.2 mm (Arnold Bott, Zurich, Switzerland) connected
to a microsyringe (Hamilton, Bonaduz, Switzerland),
10 ml of a sterilized 25% solution of FITC–DextranPatients and methods
(fluorescein isothiocyanate–dextran 150 000 molecular
Healthy controls and patients weight; Sigma Chemical, St Louis, MO, USA) were
injected into the subepidermal layer of the skin. TheThe group of 16 healthy controls comprised 12 women
injected FITC–Dextran was visualized by a fluorescenceand four men (mean age± s.d. 62.3± 13.1 yr; range
videomicroscopy system consisting of an incident-light38–81 yr). None of them had actual finger swelling,
fluorescence microscope with a mercury vapour lampprevious history of swelling or clinical signs of connect-
(Leica, Heerbrugg, Switzerland) mounted on a heavyive tissue disease.
support (Foba, Zurich, Switzerland), a 3-CCD video-The 16 patients with systemic sclerosis comprised 14
camera (Model DXC-930, Sony, Tokyo, Japan) with awomen and two men (mean age± s.d. 58. 9± 13.6 yr;
camera adapter (CMA-D2, Sony), a video timer andrange 33–76 yr). The patients are participating in a
scale marker (For-A-Company, Tokyo, Japan), a video-longitudinal assessment of the Swiss League against
monitor (Picture Monitor Model PM 171T, IkegamiRheumatism and had a work-up with extensive clinical
Tsushinki, Tokyo, Japan) and a video recorderexaminations. If not previously performed, laboratory
(S-VHS, AG-7350-E, Panasonic, Osaka, Japan). Thetesting, chest X-ray, electrocardiography, echocardio-
microscope was equipped with 1.0/0.04, 2.5/0.08,graphy, respiratory function tests (spirometry, plethys-
6.3/0.20 and 10/0.25 planar objectives (Leica,mography and pulmonary diVusion capacity) and, if
Heerbrugg, Switzerland), which allow a magnificationclinically indicated, cineradiography of the oesophagus,
of ×24, ×62, ×165 and ×240 on the monitor, respect-were conducted. All patients fulfilled the American
ively. The fluorescence excitation filter worked at 450–College of Rheumatology (ACR) Scleroderma Co-
490 nm and the barrier filter at 515 nm.operative Study Criteria [14] for the disease, i.e. one
The subjects were sitting on a chair and the hand wasmajor criterion (proximal scleroderma) or two or more
put on the stage of the microscope. The measurementsminor criteria (sclerodactyly, digital pitting scars of
were performed after a resting time of at least 10 minfingertips or loss of substance of the distal finger pad,
in a temperature-controlled room (22–24°C).bilateral basilar pulmonary fibrosis). Eleven patients
First, conventional microscopy of the nailfold bloodhad the limited and five patients the diVuse form of
capillaries of the third finger of the right hand wassystemic sclerosis. The mean duration of the disease was
performed using the 2.5/0.08, 6.3/0.20 and 10/0.25 planar10.0± 13.3 yr (range 1–49 yr). Fifteen patients suVered
objectives (magnification ×62, ×165 and ×240,from secondary Raynaud’s phenomenon (94%) and 15
respectively). Then, fluorescence microlymphographypatients had sclerodactyly (94%). Actual or previous
was performed on the dorsum of the middle phalanx oftrophic changes to the fingertips were present in 15
the middle finger of the right hand. After injection ofpatients (94%). Five patients had finger swelling at the
0.01 ml of dye into the subepidermal layer of the skin,time of investigation (31%). Telangiectasis of the skin
the deposit and the filling of the lymphatic capillarieswas found in 14 patients (88%). Dysphagia or dyspepsia
were observed during a time period of 10 min and storedwas present in 11 patients (69%) and cineradiography
on videotape. The planar objective 1.0/0.04 (magnifica-of the oesophagus was abnormal in six of 10 patients
tion ×24) was used during the whole observation timeinvestigated. Pulmonary diVusion capacity was reduced
and after 10 min was changed to the 2.5/0.08 (magni-in 10 patients (63%). Advanced renal insuYciency was
fication ×62) objective. The whole observation fieldnot found among these patients. Two patients had
was then re-examined using this magnification. In themild renal insuYciency (creatinine level >105 mmol/l,
case of absence of visualized lymphatic capillaries, abut <125 mmol/l ) (13%). Antinuclear antibodies were
second injection was performed to confirm the finding.positive in 15 patients (94%), anti-Scl-70 antibodies in
The same procedure was used at the dorsum of theseven patients (44%) and anti-centromere antibodies in
hand in all subjects and at the dorsal proximal forearmthree patients (19%).
in all healthy controls and in six patients (all clinically
Technique of investigation without involvement of the skin in this area).
The study protocol was approved by the ethicalThe investigation was based on the technique of fluores-
cence microlymphography, which has been described in committee of the Department of Internal Medicine,
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Fig. 1. Fluorescence microlymphography at the dorsum of
Fig. 3. Fluorescence microlymphography at the dorsum ofthe finger 10 min after injection of the dye in a 66-yr-old
the hand 10 min after injection of the dye in a 48-yr-old femalefemale patient with systemic sclerosis for 49 yr. Only the dye
healthy control. A lymphatic capillary network consisting ofdeposit is visible, no lymphatic capillaries are stained at all.
a few meshes is stained. Magnification ×62. Left, distal;Magnification ×24. Left, distal; above, ulnar. The arrow is
above, ulnar.the injection site.
Fig. 2. Fluorescence microlymphography at the dorsal fore-
arm 10 min after injection of the dye in a 50-yr-old female
healthy control. Single lymphatic capillaries are visualized.
Magnification ×24. Left, distal; above, ulnar.
Fig. 4. Fluorescence microlymphography at the dorsum of
the hand 10 min after injection of the dye in a 33-yr-old female
University Hospital, Zurich. Healthy controls and patient with systemic sclerosis for 1 yr. A large lymphatic
patients gave written informed consent for the network is stained. Magnification ×62. Left, distal; above,
investigation. ulnar.
Measurements
fragmentation of the superficial lymphatic capillaryThe following parameters were evaluated oV-line from network 10 min after dye injection (defined asthe videotape: lymphatic capillary network with interruptions of
the meshes);(a) Presence or absence of:
blood capillary microangiopathy (patients with avas- cutaneous backflow (reappearance of the fluorescent
dye at the surface in islets composed of depictedcular fields or giant blood capillaries (capillary dia-
meter >50 mm) were defined as having micro- meshes away from the main network) at 10 min.
(b) Maximal intralymphatic extension of the dye apartangiopathy of the blood capillaries [1]);
visualized lymphatic capillaries 10 min after dye from the depot in the proximal, distal, radial and
ulnar direction, as well as maximal extension 10 mininjection;
a superficial lymphatic capillary network (defined as after dye injection.
(c) Diameter of single lymphatic capillaries at 10 minat least three lymphatic capillary meshes) 10 min
after dye injection; (only subjects in whom at least three lymphatic
A. J. Leu et al.224
capillaries could be measured were considered and observed in two patients, but in none of the controls
(n.s.). Again, maximal extension of the lymphatic net-the mean value of at least three measurements at
diVerent sites of the same capillary was taken). work was significantly greater in patients compared to
controls, involving also the proximal, distal, ulnar and
Statistical analysis radial directions. Mean diameters of the lymphatic capil-
Statistical analysis was performed on a personal com- laries were comparable in both groups (Table 1).
puter (Macintosh II ci, Apple Computer, Cupertino, Forearm. As with the other sites investigated, all
CA, USA) with use of a statistical program (Stat View healthy controls exhibited at least one lymphatic capil-
4.02, Abacus Concepts, Berkeley, CA, USA). Results lary, extending to a capillary network in seven subjects.
are expressed as means± s.d. x2 test or the Mann– At the same time point, two of the six patients investi-
Whitney U-test were used as appropriate. P∏ 0.05 was gated had a lymphatic capillary network and four had
considered significant. single lymphatic capillaries (all patients without clinical
scleroderma of the forearm; n.s.). No fragmentation
or cutaneous backflow was observed in patients andResults
controls. In addition, extension of the lymphatic network
and the mean diameter of lymphatic capillaries wereNailfold blood capillary microscopy
similar in both groups (Table 1).Blood capillary microangiopathy was present in none
of the healthy controls, but in 12 of 14 patients. In two Correlation between microlymphography and clinical
patients, capillary microscopy was inconclusive because findings
of impaired skin transparency. Another two patients
The correlation analysis revealed a significant positiveshowed normal blood capillaries at the nailfold (one
correlation between duration of disease and lack ofwoman with the diVuse type of systemic sclerosis and a
lymphatic capillaries at the finger (P< 0.05). No cor-disease duration of 9 yr, and another female patient
relation could be found between the other parameterswith the limited form and a disease duration of 49 yr).
evaluated by fluorescence microlymphography or bloodOf the 12 patients with blood capillary microangiopathy,
capillary microscopy and all other clinical data (i.e.10 exhibited both giant capillaries and avascular fields.
gender, age, type of systemic sclerosis, Raynaud’sTwo patients had avascular fields only.
phenomenon, finger swelling, sclerodactyly, trophic
changes, telangiectasis, dysphagia or dyspepsia, pulmon-Lymphatic capillary microscopy
Dorsum of the finger. Ten minutes after injection of ary diVusion capacity, renal function, antibodies).
the fluorescent dye, 13 controls showed single lymphatic
capillaries (Table 1). In another three, a lymphatic capil- Discussion
lary network was visible. By contrast, in five patients
the absence of any lymphatic microvessel was observed These data represent the first intravital investigations to
study the microlymphatic system of the skin in systemic(P< 0.05). Single lymphatic capillaries were visualized
in five patients, and six patients exhibited a lymphatic sclerosis. The technique of fluorescence microlympho-
graphy [15] was used, which allows visualization andcapillary network. Fragmentation of the lymphatic capil-
lary network was found in three of the six patients investigation of the superficial cutaneous lymphatic
capillary network.presenting a capillary network, but in none of the
three corresponding controls [not significant (n.s.)] The main findings of this study were as follows: in
clinically aVected areas, patients with systemic sclerosis(Figs 1–4). Cutaneous backflow of the dye was exclus-
ively observed in patients (3/16; P< 0.05 vs control ). showed the pattern of lymphatic microangiopathy,
known from patients with lymphoedema and chronicMean maximal extension of the visualized lymphatic
network was significantly increased in patients compared venous insuYciency [3–5], characterized by increased
extension of the visualized lymphatic capillaries andto controls (8.1± 6.0 vs 2.0± 1.2 mm; P< 0.0001),
which also accounted for the extension of the network cutaneous backflow or even the complete absence of
stained microlymphatics. The frequency of these findingsin the proximal, distal, ulnar and radial directions. No
statistically significant diVerence between the groups was increased from the proximal to the distal hand. No
significant diVerences were found at the forearm, which,found for mean diameter of the lymphatic capillaries
(Table 1). Table 2 gives the results of the finger investi- however, was not clinically aVected.
The finding of an increased extension of the fluor-gation for the patients, subdivided into three disease
duration groups, and although the numbers are small, escent dye in the superficial lymphatic capillary network
is known from patients with primary or secondaryhelps to illustrate trends.
Dorsum of the hand. In all healthy controls, at least lymphoedema of both the upper or lower legs, and from
patients with chronic venous insuYciency [5, 19–21]. Itone lymphatic capillary was visible and three subjects
showed a lymphatic capillary network. In contrast, there is the most important parameter of this technique for
the diagnosis of lymphoedema and mild chronic venouswas a lack of lymphatics in three patients, whereas nine
exhibited single capillaries and four showed a lymphatic insuYciency.
The phenomenon of cutaneous backflow (reappear-capillary network. In parallel to the findings of the
dorsum of the finger, a fragmented network was ance of the fluorescent dye at the surface in islets
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Table 2. Fluorescence microlymphography at the dorsum of the finger. The patients are subdivided into three disease duration groups. Although
the numbers are small, these data illustrate trends
0–5 yr 6–15 yr >15 yr
n= 9 P n= 5 P n= 2
Single lymphatic capillaries 6 0 0
Lymphatic capillary network 3 3 0
No visible lymphatic capillaries 0 <0.05 2 2
Fragmentary network 2/3 n.s. 1/3 –
Cutaneous backflow 3/9 n.s. 0/5 n.s. 0/2
Maximal network extension (mm) 5.6± 2.1 <0.05 14.7± 8.6 –
Lymphatic capillary diameter (mm) 0.087± 0.09 n.s. 0.112± 0.02 –
composed of depicted meshes away from the main there is also a vast range of pathology. However, there
is a correlation of disease duration and complete disap-network) is another well-known finding in patients with
lymphoedema or chronic venous insuYciency, not pearance of the lymphatic network, at least at the
dorsum of the finger. This finding supports the hypo-known in a healthy population [5, 20, 21].
It is assumed that increased dye expansion into the thesis of a cascade of lymphatic microangiopathy in
systemic sclerosis: leakage of the skin blood capillaries—superficial lymphatic capillary network and cutaneous
backflow are the result of an impeded drainage of increased amount of fluid and macromolecules in the
interstitial space—maximal augmentation of lymphinterstitial fluid from the skin into the deeper main
collectors. Thus, the superficial lymphatic capillary flow—finally lymphatic insuYciency—protein-rich
interstitial fluid retention—fibrotic process and furthernetwork acts as an overflow basin [22]. The underlying
causes in these patients include aplasia, hypoplasia or, damage to the microlymphatics. Thus, a vicious circle
similar to chronic venous insuYciency may occur.in patients with secondary lymphoedema, destruction of
large lymphatic collectors [23]. The finding of unchanged capillary diameters in
patients with systemic sclerosis is not surprising as theFragmentation of the lymphatic capillary network,
i.e. damaged microlymphatics, is found in patients with same situation is also found in patients with lymph-
oedema [26 ].lymphoedema following erysipelata [20], or in patients
with severe chronic venous insuYciency [5, 24]. In conclusion, lymphatic microangiopathy may, at
least in part, explain oedema in patients with systemicComplete destruction of the superficial lymphatic
capillary network is known from patients with severe sclerosis. The empirical finding that manual lymph
drainage improves the swelling in these patients [27]recurrent erysipelata or with severe chronic venous
insuYciency [5, 20]. In these patients, several subepider- seems to have a rational basis. It is possible that another
classical treatment in patients with lymphoedema, com-mal dye injections fail to visualize any lymphatic micro-
vessels. The same situation is also found in patients with pression therapy, may also have a beneficial eVect, at
least in the oedematous stage of the disease. The sameNonne–Milroy’s disease, a congenital form of primary
lymphoedema, where aplasia of the superficial lymphatic can be postulated for drug treatment [28].
network of the skin takes place [25].
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